跳至主要内容
临床试验/CTRI/2021/06/034030
CTRI/2021/06/034030尚未招募不适用

A preclinical and clinical study to determine the efficacy of Neelkanthi Churna in management of Madhumeha w.s.r to Type 2 Diabetes Mellitus

Principal1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年6月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
Principal
入组人数
30
试验地点
1
主要终点
Fulfillment of objective and subjective criteria

研究概览

简要总结

I would like to publish my research trial after completion of the trial as soon as possible. Patients will selected from OPD & IPD of R.G.G.P.G Ayurvedic College & Hospital Paprola.

3 groups of 30 patients will be registered then assessed to evaluate the efficacy of Neelkanthi Churana in Madhumeha w.s.r Diabetes Mellitus Type 2

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients of either sex aged between 20-70yrs.
  • Newly diagnosed patients of Type 2 Diabetes Mellitus having glycosylated Hb (HbA1C) between 6.5% to 10% 3) Patients willing to participate in the trial.

排除标准

  • Subject of Type-1 DM or Type-2 DM on insulin/OHA’s other than Metformin/ any other medication for glucose control in the last 3 months Subjects suffering from the complications of Diabetes Mellitus viz., diabetic neuropathy, diabetic nephropathy, diabetic retinopathy etc.
  • which require an urgent treatment.
  • Patients having major medical illness like cancer, concurrent infection like tuberculosis.
  • Patients with uncontrolled Hypertension.
  • Patients with established diagnosis of CAD or any other clinically significant cardiovascular disease.
  • Renal dysfunction (defined by eGFR< 60ml/min calculated by MDRD calculator) Subjects who have completed participation in any other clinical trial during the past 3 months.
  • Any other condition which the investigator thinks may compromise the safety of subject.
  • Subjects with Haemoglobin percentage < 9gm% for males and < 8gm%for females.

结局指标

主要结局

Fulfillment of objective and subjective criteria

时间窗: 12 weeks

次要结局

  • Efficacy of Neelkanthi Churna in type 2 Diabetes Mellitus(12 weeks)

研究者

发起方
Principal
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验